Kerecis Omega3 Wound is a decellularized intact fish skin developed for the management of chronic wounds, such as diabetic wounds, pressure ulcers, and vascular ulcers, as well as surgical wounds, trauma wounds and other wounds which are commonly treated in the private office and wound care centers. The fish skin sheets contain fat, protein, elastin, glycans and other natural skin elements and are provided in different sizes.
Indications For Use
- Diabetic ulcers
- Chronic vascular ulcers
- Venous ulcers
- Trauma wounds (including abrasions, lacerations and skin tears),
- Acute surgical wounds (including debridement, amputation and donor sites)
- Surgical wounds (dehiscence or failed healing after surgery)
- Imminent failure of split thickness skin graft
- Post-Injection Necrosis
Disclaimer
Kerecis® Omega3 Wound is not available in all countries and may be known under different trade names. Products, product names, indications and claims vary between jurisdictions.
Important Information
Need more information?
From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory approvals in the United States, Europe, and beyond.